These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17922472)

  • 1. PAI-1 activity, but not fibrinogen or von Willebrand factor, is inversely related to LDL particle size in type 2 diabetes.
    Mertens I; Lemieux I; Verrijken A; Després JP; Van Gaal LF
    Diabetes Metab Res Rev; 2008 Feb; 24(2):141-7. PubMed ID: 17922472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostasis and fibrinolysis in non-diabetic overweight and obese men and women. Is there still a role for leptin?
    Mertens I; Considine RV; Van der Planken M; Van Gaal LF
    Eur J Endocrinol; 2006 Sep; 155(3):477-84. PubMed ID: 16914603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is visceral adipose tissue a determinant of von Willebrand factor in overweight and obese premenopausal women?
    Mertens I; Van der Planken M; Corthouts B; Van Gaal LF
    Metabolism; 2006 May; 55(5):650-5. PubMed ID: 16631442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inverse relationship between plasminogen activator inhibitor-I activity and adiponectin in overweight and obese women. Interrelationship with visceral adipose tissue, insulin resistance, HDL-chol and inflammation.
    Mertens I; Ballaux D; Funahashi T; Matsuzawa Y; Van der Planken M; Verrijken A; Ruige JB; Van Gaal LF
    Thromb Haemost; 2005 Dec; 94(6):1190-5. PubMed ID: 16411393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
    De Pergola G; De Mitrio V; Sciaraffia M; Pannacciulli N; Minenna A; Giorgino F; Petronelli M; Laudadio E; Giorgino R
    Metabolism; 1997 Nov; 46(11):1287-93. PubMed ID: 9361687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dense LDL phenotype. Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men.
    Tchernof A; Lamarche B; Prud'Homme D; Nadeau A; Moorjani S; Labrie F; Lupien PJ; Després JP
    Diabetes Care; 1996 Jun; 19(6):629-37. PubMed ID: 8725863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
    Iida K; Tani S; Atsumi W; Yagi T; Kawauchi K; Matsumoto N; Hirayama A
    Coron Artery Dis; 2017 Nov; 28(7):577-587. PubMed ID: 28692480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue.
    Targher G; Bertolini L; Scala L; Zoppini G; Zenari L; Falezza G
    Diabet Med; 2005 Oct; 22(10):1354-8. PubMed ID: 16176196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.
    De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R
    Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small, dense LDL particle concentration correlates with plasminogen activator inhibitor type-1 (PAI-1) activity.
    Väisänen S; Baumstark MW; Penttilä I; Bouchard C; Halonen P; Rankinen T; Berg A; Rauramaa R
    Thromb Haemost; 1997 Dec; 78(6):1495-9. PubMed ID: 9423801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of abdominal visceral and subcutaneous adipose tissue with lipoprotein particle number and size in type 2 diabetes.
    Sam S; Haffner S; Davidson MH; D'Agostino RB; Feinstein S; Kondos G; Perez A; Mazzone T
    Diabetes; 2008 Aug; 57(8):2022-7. PubMed ID: 18469202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
    Zareba W; Pancio G; Moss AJ; Kalaria VG; Marder VJ; Weiss HJ; Watelet LF; Sparks CE
    Thromb Haemost; 2001 Sep; 86(3):791-9. PubMed ID: 11583309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Among inflammation and coagulation markers, PAI-1 is a true component of the metabolic syndrome.
    Mertens I; Verrijken A; Michiels JJ; Van der Planken M; Ruige JB; Van Gaal LF
    Int J Obes (Lond); 2006 Aug; 30(8):1308-14. PubMed ID: 16389265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance is accompanied by increased von Willebrand factor levels in nondiabetic women: a study of offspring of type 2 diabetic subjects compared to offspring of nondiabetic subjects.
    Foss CH; Vestbo E; Frøland A; Ingerslev J; Gjessing HJ; Mogensen CE; Damsgaard EM
    J Intern Med; 2002 Aug; 252(2):155-63. PubMed ID: 12190891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral adipose tissue and low-density lipoprotein particle size in middle-aged versus young men.
    Lemieux I; Pascot A; Tchernof A; Bergeron J; Prud'homme D; Bouchard C; Després JP
    Metabolism; 1999 Oct; 48(10):1322-7. PubMed ID: 10535398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of plasminogen activator inhibitor-1 4G/5G gene polymorphism with variations in the LDL particle size in healthy Japanese men.
    Kitamura Y; Okumura K; Imamura A; Mizuno T; Tsuzuki M; Numaguchi Y; Matsui H; Murohara T
    Clin Chim Acta; 2004 Sep; 347(1-2):209-16. PubMed ID: 15313160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between plasma soluble thrombomodulin levels and insulin resistance syndrome in type 2 diabetes: a comparison with von Willebrand factor.
    Aso Y; Fujiwara Y; Tayama K; Takanashi K; Inukai T; Takemura Y
    Exp Clin Endocrinol Diabetes; 2001; 109(4):210-6. PubMed ID: 11453033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.
    Berneis K; Jeanneret C; Muser J; Felix B; Miserez AR
    Metabolism; 2005 Feb; 54(2):227-34. PubMed ID: 15690318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels. The Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Mykkänen L; Tracy R; Howard BV; Haffner SM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):605-10. PubMed ID: 10073963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevation of plasminogen activator inhibitor 1 in borderline hypertension is linked to concomitant metabolic disturbances.
    Lemne C; De Faire U
    Eur J Clin Invest; 1996 Aug; 26(8):692-7. PubMed ID: 8872066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.